Header image
Simplifying Oncology Care
          Home    About APS    Pipeline    FAQs    Investors    Media    Contact Us
 
 
 
 

 
 
Media

Please watch this space for public announcements related to Applied Protein Sciences.

2009


Apr 29, 2009: First pre-IND meeting between APS and FDA scheduled.

Apr 28, 2009: APS and Biomodels Collaborate to Boost Supportive Cancer Care.
View press release on the websites below, or view them all on the Scribd window on the right:

Feb 20, 2009: APS in-licenses 3 patents to expand its pipeline to include pain relief for supportive oncology.

Feb 15, 2009: APS releases a proposed "Mechanism of Action for AP002".

Jan 22, 2009: Maynard Lichty joins the APS team as Consultant for Product Development.

2008


Dec 13, 2008: Shelley Ching joins the APS team as Consultant for Non-Clinical Development.

Nov 23, 2008: Marna Doucette joins APS team as Consultant for Regulatory Affairs.

Oct 7, 2008: APS launches a comprehensive pre-clinical program for AP002.

Sept 15, 2008: APS announces AP002 pre-clinical results. APS releases pre-clinical test results for its proprietary compound AP002 showing a dramatic activity in mucosal cell proliferation.

June 24, 2008: APS presented at the New York Venture Summit, New York.

June 3, 2008: APS invited to present at the Life Sciences Festival, Sacramento.

Apr 29, 2008: APS patents in the news.

Feb 12, 2008: APS awarded another US patent, US7329645, related to its mucositis platform.



Educational Links